Evidence map›Paper›PMID 39958381›Full record

ArticleLiver research (Beijing, China)2023

Liver retransplants using living donors: An approach for management.

Hasan Al Harakeh, Christopher Hughes, Amit Tevar, Vikram Gunabushanam, Eishan Ashwat, Hao Liu, Abhinav Humar

Abstract read
In one paragraph

Article in Liver research (Beijing, China), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hasan Al HarakehStarzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Christopher HughesStarzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Amit TevarStarzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Vikram GunabushanamStarzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Eishan AshwatStarzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Hao LiuStarzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Abhinav HumarStarzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aims: Many centers do not offer living donor transplants for patients in need of a liver retransplant. We aimed to study our liver retransplant outcomes using living donors and compared them with those of retransplants performed using deceased donors. Methods: This study retrospectively analyzed all retransplants performed at our center between 2009 and 2023, and outcomes of living donor retransplants were compared with deceased donor retransplants using standard statistical tests. Results: Between January 2009 and March 2023, a total of 77 retransplants, 60 with deceased donors and 17 with living donors, were performed. Important demographic differences between the two groups included a higher model for end-stage liver disease score in the deceased donor group (32.1 ± 6.1 Conclusions: Living donors can provide acceptable outcomes for those in need of a retransplant, with results comparable to those seen with deceased donors. A systematic approach to the patient in the pre-, peri-, and post-transplantation period is important in these complicated cases.

Indexed as

ComplicationsDeceased donorLiver retransplantLiving donor liver transplantOutcomes

Identifiers

PMID39958381
PMCPMC11791900

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.